Assay of ezetimibe in bulk and in its pharmaceutical formulations by spectrophotometry

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 396-401

  Sekaran, Chandra Bala ^a   Tirupatamma, Pamulapati Lakshmi ^a   Rajitha, Vutla ^a   Vishnupriya, Kalluri ^a   Jayasree, Bandarupalli ^a  

^a Jagarlamudi Kuppuswamy Choudary College   (India)

Author keywords

2,2' bipyridyl; Ezetimibe; Potassium dichromate; Spectrophotometric analysis

Indexed keywords

2, 2' BIPYRIDINE; DICHROMATE POTASSIUM; EZETIMIBE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DOSAGE FORM; DRUG FORMULATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 84873490946     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Knopp RH, Gitter H, Truitt T, Bays H, Manion CV, Lipka LJ, et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 2008; 24: 729-741.
2. Gagné C, Bays HE, Weiss SR, Mata P, Quinto K, Melino M, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002; 90: 1084-1091.
3. Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, doubleblind, placebo-controlled trial. Mayo Clin Proc 2004; 79: 620629.
4. Guyton JR, Betteridge DJ, Farnier M, Leiter LA, Lin J, Shah A, et al. Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes. Diab Vasc Dis Res 2011; 8: 160-172.
5. Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, et al. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimib e/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. Clin Ther 2004; 26: 1758-1773.
6. El-Moghazy SM, El-Azem Mohamed MA, Mohamed MF, Youssef NF. Development and Validation of HPLC, TLC and Derivative spectrophotometric methods for the analysis of ezetimibe in the presence of alkaline induced degradation products. J Chinese Chem Soc 2009; 56: 360-367.
7. Sistla R, Tata VS, Kashyap YV, Chandrasekar D, Diwan PV. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. J Pharmaceut Biomed Anal 2005; 39: 517-522.
8. Akmar SK, Lata K, Thomas A, Sumitra J, Deshpande AD. Reverse phase high performance liquid chromatography method for estimation of ezetimibe in bulk and pharmaceutical formulations. Indian J Pharm Sci 2007; 69: 695-697.
9. Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay. J Pharmaceut Biomed Anal 2006; 41: 1037-1040.
10. Doshi AS, Kachhadia PK, Joshi HS. Validation of a stability-indicating LC method for assay of ezetimibe in tablets and for determination of content uniformity. Chromatographia 2008; 67: 137-142.
11. Basha SJS, Naveed SA, Tiwari NK, Shashikumar D, Muzeeb S, Kumar TR, et al. Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: Quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile. J Chromat B 2007; 853: 88-96.
12. Oswald S, Scheuch E, Cascorbi I, Siegmund W. A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1J. J Chromat B Analyt Technol Biomed Life Sci 2006; 830: 143-150.
13. Li S, Liu G, Jia J, Li X, Yu C. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma. J Pharmaceut Biomed Anal 2006; 40: 987-992.
14. Oliveira PR, Junior LB, Fronza M, Bernardi LS, Masiero SMK, Dalmora SL. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ezetimibe in human plasma and pharmaceutical formulations. Chromatographia 2006; 63: 315320.
15. Bahrami G, Mohammadi B, Khatabi PM, Farzaei MH, Majnooni MB, Bahoosh SR. Application of one-step liquid chromatography-electrospray tandem MS/MS and collision-induced dissociation to quantification of ezetimibe and identification of its glucuronated metabolite in human serum: A pharmacokinetic study. J Chromat B 2010; 878: 2789-2795.
16. Yola ML, Ozaltin N. Adsorptive stripping voltammateric methods for determination of ezetimibe in tablets. Rev Anal Chem 2011; 30: 29-36.
17. Uçaktūrk E, Ozaltin N, Kaya B. Quantitative analysis of ezetimibe in human plasma by gas chromatography-mass spectrometry. J Sep Sci 2009; 32: 1868-1874.
18. Lakshmi PBS, Ramchandran D, Rambabu C. Spectrophotometric Determination of Ezetimibe. E-J Chem 2010; 7: 101-104.
19. Shravya A, Chandan RS, Gurupadayya BM, Sireesha M. Spectrophotometric determination of ezetimibe using MBTH reagent in pharmaceutical dosage form. Int J Res Ayur Pharm 2011; 2: 521-525.
20. Sharma M, Mhaske DV, Mahadik M, Kadam SS, Dhaneshwar SR. UV and three derivative spectrophotometric methods for determination of ezetimibe in tablet formulation. Indian J Pharm Sci 2008; 70: 258-260.
21. Howells KW. The determination of serum iron with ferricyanide. J Clin Pathol 1949; 2: 290-291.
22. Lucena-Conde F, Prat L. A new test for uranyl ions based on its redox properties. Microchim. Acta 1955; 43: 799-802.
23. Moss ML, Mellon MG. Colorimetric Determination of Iron with 2, 2'-Bipyridyl and with 2, 2', 2'-Terpyridyl. Ind Eng Chem Anal Ed 1942; 14: 862-865.
24. Smith FE, Herbert J, Gaudin J, Hennessy DJ, Reid GR. Serum iron determination using ferene triazine. Clin Biochem 1984; 17: 306-310.
25. Rodriguez JC, Barciela J, García S, Herrero C, Peña RM. Optimization of two flow-injection spectrophotometric methods for the determination of indapamide in pharmaceutical dosage forms. J AOAC Int 2005; 88: 11481154.
26. Syeda A, Mahesh HRK, Syed AA. 2, 2'-Bipyridine as a new and sensitive spectrophotometric reagent for the determination of nanoamounts of certain dibenzazepine class of tricyclic antidepressant drugs. II Farmaco 2005; 60: 47-51.
27. El-Shiekh R, Amin AS, Zahran F, Gouda AA. Spectrophotometric determination of pipazethate hydrochloride in pure form and in pharmaceutical formulations. J AOAC Int 2007; 90: 686-692.
28. Amin AS, Ragab GH. Spectrophotometric methods for the determination of anti-emetic drugs in bulk and in pharmaceutical preparations. Anal Sci 2003; 19: 747-751.
29. Nagaralli BS, Seetharamappa J, Melwanki MB. Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations. J Pharmaceut Biomed Anal 2002; 29: 859-864.
30. Syeda H, Akalanka D, Raju SA, Syed S. Applications of colorimetric methods for the determination of cinitapride hydrogen tartarate in drug formulations. Int J Pharm Pharm Sci 2010; 2 (Suppl 1): 134-136.
31. Gousuddin Md, Raju SA, Sultanuddin, Shobha M. Development and validation of spectrophotometric methods for estimation of formoterol bulk drug and its pharmaceutical dosage forms. Int J Pharm Pharm Sci 2011; 3: 306-309.
32. Sultan SM. Spectrophotometric determination of paracetamol in drug formulations by oxidation with potassium dichromate. Talanta 1987; 34: 605-608.
33. Basavaiah K, Swamy JM. Application of potassium dichromate and iron-thiocyanate in the spectrophotometric investigations of phenothiazines. Farmaco 2001; 56: 579-585.
34. Anwar J, Awan TA. Spectrophotometric determination of aspirin in pharmaceutical formulations by oxidation with potassium dichromate. J Chem Soc Pakistan 1990; 12: 30-33.
35. Revanasiddappa HD, Mallegowda SM, Deepakumari HN, Vinay KB. Spectrophotometric determination of nitrazepam and nimodipine in pure and the tablet dosage forms. Asian J Biochem Pharm Res 2011; 1: 70-77.
36. Noroozifar M, Khorasani-Motlagh M. Application of potassium chromate-diphenylcarbazide in the quantitative determination of ascorbic acid by spectrophotometry. Turkish J Chem 2003; 27: 717-722.